NASDAQ:ARDX

Ardelyx Stock Insider Trading

etoro logo Buy ARDX
*Your capital is at risk
$5.42
-0.1000 (-1.81%)
At Close: Jun 03, 2026

Ardelyx Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 26.47. In total, the insiders bought 5.74M and sold 637.1K ARDX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
26.47
Buy 5.74M shares
Sell 637.1K shares
41% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
May 21, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 26.47.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jan 23, 2026
Buy
Stock Option (Right to Buy)
A-Award
Bishop John E
See Remarks
Officer 186 500
Value: $1.45M
Jan 08, 2026
Buy
Common Stock
M-Exempt
Williams Laura A
Chief Patient Officer
Officer 50 000
Value: $49.5K
Jan 08, 2026
Sell
Common Stock
S-Sale
Williams Laura A
Chief Patient Officer
Officer 50 000
Value: $348.9K
Jan 08, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Williams Laura A
Chief Patient Officer
Officer 0
Value: $0
Nov 21, 2025
Sell
Common Stock
S-Sale
Reilly Joseph James
See Remarks
Officer 11 086
Value: $61.4K
Nov 21, 2025
Sell
Common Stock
S-Sale
Foster Eric Duane
Chief Commercial Officer
Officer 5 814
Value: $32.2K
Nov 21, 2025
Sell
Common Stock
S-Sale
Williams Laura A
Chief Patient Officer
Officer 6 426
Value: $35.6K
Nov 21, 2025
Sell
Common Stock
S-Sale
Kelliher Mike
See Remarks
Officer 5 560
Value: $30.8K
Nov 21, 2025
Sell
Common Stock
S-Sale
Grammer Elizabeth A
See Remarks
Officer 5 995
Value: $33.2K
Nov 21, 2025
Sell
Common Stock
S-Sale
Raab Michael
President & CEO
CEO / President 46 887
Value: $259.6K
Nov 04, 2025
Buy
Stock Option (Right to Buy)
Hohenleitner Susan
Chief Financial Officer
C-Suite Officer 578 104
Value: $2.90M
Nov 04, 2025
Buy
Common Stock
Hohenleitner Susan
Chief Financial Officer
C-Suite Officer 0
Value: $0
Aug 26, 2025
Buy
Common Stock
M-Exempt
Williams Laura A
Chief Patient Officer
Officer 50 000
Value: $49.5K
Aug 26, 2025
Sell
Common Stock
S-Sale
Williams Laura A
Chief Patient Officer
Officer 50 000
Value: $306.1K
Aug 26, 2025
Sell
Common Stock
S-Sale
Williams Laura A
Chief Patient Officer
Officer 30 000
Value: $183.6K
Aug 26, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Williams Laura A
Chief Patient Officer
Officer 50 000
Value: $49.5K
Aug 26, 2025
Sell
Common Stock
S-Sale
Williams Laura A
Chief Patient Officer
Officer 30 000
Value: $183.6K
Aug 26, 2025
Sell
Common Stock
S-Sale
Williams Laura A
Chief Patient Officer
Officer 50 000
Value: $306.1K
Aug 21, 2025
Sell
Common Stock
S-Sale
Kelliher Mike
Chief Business Officer
Officer 5 417
Value: $32.1K
Aug 01, 2025
Buy
Stock Option (Right to Buy)
Conner Edward R.
Chief Medical Officer
Officer 463 268
Value: $2.41M
Aug 01, 2025
Buy
Common Stock
Conner Edward R.
Chief Medical Officer
Officer 0
Value: $0
Aug 01, 2025
Buy
Stock Option (Right to Buy)
Bishop John E
See Remarks
Officer 327 000
Value: $1.47M
Aug 01, 2025
Buy
Common Stock
Bishop John E
See Remarks
Officer 0
Value: $0
Jun 18, 2025
Buy
Stock Option (Right to Buy)
Brady James Parker
Chief Human Resources Officer
Officer 250 000
Value: $982.5K
Jun 18, 2025
Buy
Common Stock
Brady James Parker
Chief Human Resources Officer
Officer 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ARDELYX
Ardelyx
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE